U.S. Markets open in 7 hrs 40 mins

Palatin Technologies, Inc. (PTN)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.3984-0.02 (-5.14%)
At close: 4:02PM EDT
People also watch
RNNMSTXHEBCVMCYTR
  • Class action soon
  • This stock is nothing more than a Vegas bet. In a few years, once they are up for fda approval, hype on mainstreet could bring it up to over a buck easy. But before that, you can also easily see it trade down into the 20s. I'd be a buyer at 25 cents, with play money only of course, like Jerky's life savings...or the total amount he's spent on education and hygiene products, lmao...bahahaha! 😂
  • With support at 30 cents, all we need is a 10 cent drop, I wouldn't mind owning at 30 cents...once Brem gets mainstream exposure, hype will run this up easy. There's no doubt this will hit 30 within 2 years easyyy.....
  • Hey John, was there any SELL SIGNAL on your site that you neglected to mention? Is there one now? Those longs who may have unfortunately calculated Johns messages into their decision to buy, should know that he refuses to post SELL signals when they appear in his trading data. So if you went long on his advice and a sell signal came up prior to yesterday, you should be thankful for him not telling you. I mean, why take a profit when you can take a loss!!
  • I listened to the conference call and I now understand where the selling pressure was coming from. The penny warrants were exercised and the stock was sold thus increasing the number of shares. This was not short selling pressure, This was warrant holders taking profits. The positive side to this equation is that there are more shares now available to be traded and those buyers between .30-48 now own shares. There is dilution of course. Based on management's projections, they will have plenty of money to do their other drugs.
  • Ashley get to your empty head that this stock will never drop to .30 again. Got it now ??
    Good luck longs.
  • I just dumped this trash yesterday!
  • Many of you have read John's "chart comments" about buying the stock. Several have noted he never posts a sell signal. Below I show you today's "report" from Stoxline, the free service John quotes from. As seen below, John doesn't post the strong sells, only the buys. So for today:

    Here's the latest from where John gets his faux-analysis. If there was ever any doubt about his BS and his lack of integrity, note what he isn't posting :
    Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.
  • Good suggestion Ashley, in case Yfest's post mysteriously vanishes:
    "
    Yfest
    8 hours ago
    Here's the latest from where John gets his faux-analysis. If there was ever any doubt about his BS and his lack of integrity, note what he isn't posting :
    Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued."
  • At least I want to see in green before closing today instead in red
  • Pretty shallow dip
  • Once this stock breaks below 30, I'm gonna start accumulating. This WILL get hyped up over a dollar easy once we get close to FDA approval as it makes a sexy story for mainstreet.
  • Strong Buy signal today on Kevins greatest hits page!
  • Been gone a while and see this has risen from the ashes. Must have been John's buy calls.

    Eh, maybe it will see $1.00 someday again....
  • Hi guys.Still listening to dumb Ashley. She lost all credibility. This stock should be .20c not .40. Dumb Ashley how long I have to wait trill you bring it down to .20. You promised me that ,and you didn't deliver. I will call you a liar and cheater then.
  • ALot of great news from the meeting , at some point they need to address the number of shares??
  • I didn't understand what they did $50 million, shown up loss and screwed the investors.
  • Finally in the green!!!!🙌🏽
  • BIG DEAL TO ACQUIRE UP TO 9 MARKETED PRODUCTS IMMINENT = 20+ BAGGER POTENTIAL !!!
    AQSZF (MC $11 M) is close to profitability and to file 3 NDA and the whole company is valued at ridiculous $11 Million ,this unknown stock is definitely one of the cheapest Biotech in the sector .Stock should be at minimum $2+ right now .

    Market Cap :US$ 11 Million
    Cash $4.1 Million << enough untill mid 2018
    Price 0.18

    MUST WATCH to realize the MONSTER POTENTIAL HERE
    https://www.dukascopy.com/tv/en/view/204408#00

    Presentation
    http://www.aequuspharma.ca/Investors/AQS%20investor%20November%202016_web.pdf

    Operational profitability estimated in 2017

    File for CDN approval of Topiramate XR in 1H 2017

    File for CDN approval of Oxcarbazepine XR in 1H 2017

    Additional Product Deals in 2017

    Partnership for AQS1301 in 2017

    Two products launches to date (Tacrolimus IR and Vistitan™)

    3 long-acting, transdermal programs in development, on track to file NDA in 2018

  • Market cap 65m value 3m stock.42 and going down figure that out